Pharmacy Times: How AI, machine learning can benefit pharmaceutical development, research
Pharmacy Times highlighted a presentation from the University of Cincinnati's Shawn Xiong discussing the potential for artificial intelligence (AI) and machine learning to bolster pharmaceutical development and research.
Xiong, PhD, assistant professor at UC's James L. Winkle College of Pharmacy, presented the American Pharmacists Association (APhA)-Academy of Pharmaceutical Research and Science Keynote at the 2024 APhA Meeting and Exposition March 22.
In the pharmaceutical industry, Xiong said the top three use cases for AI are predictive maintenance, quality inspection and assurance and manufacturing process optimization. In clinical practice, Xiong said early detection and personalized treatment are particularly exciting areas of potential.
“This is not only about identifying the disease itself,” Xiong said. “It’s also about providing insights into the unique situations of the patient so that we can make personalized treatments for the patient, especially considering the concept of patient-centered care.”
While the potential is encouraging, Xiong noted there are still limitations and concerns, including nuances of medical language and privacy and security concerns with patient data. As these issues are addressed, however, Xiong said AI and machine learning could significantly improve the future of pharmacy.
“AI and machine learning can help automate the medication filling process, improving accuracy and also saving time,” Xiong said. “The AI can help check and double-check errors in the medication orders, and they can help us identify errors and reduce errors so that patients are getting what they need and how they need it.”
Read the Pharmacy Times article.
Featured image courtesy of Adobe Stock.
Related Stories
Can you grow new brain cells?
March 6, 2026
As National Geographic recently reported, a pair of new studies have provided fresh evidence in the long-running scientific debate on if adults can grow new brain cells. The result could be game-changing for treating diseases such as Alzheimer’s and dementia.
Using GLP-1s for weight loss, maintenance after bariatric surgery
March 5, 2026
Bariatric surgery has become a cornerstone treatment for severe obesity and its related comorbidities, offering superior long-term efficacy compared with lifestyle and pharmacologic interventions alone. Yet persistent clinical gaps remain in a subset of patients, including insufficient weight loss and postoperative weight regain.
UC marketing class featured in Super Bowl Ad Meter School Spotlight
March 4, 2026
University of Cincinnati’s Lindner College of Business was one of just 16 institutions representing USA Today’s Ad Meter School Spotlight program, where students got to evaluate the ads and publish their findings alongside industry professionals. The students' top-rated commercials largely aligned with Ad Meter’s official rankings, with Budweiser's "American Icons" earning the highest score. The participants included over 300 students across two marketing classes taught by assistant professor-educator Summer Shelton. She came to the University from a marketing research firm and brings experience ranking Super Bowl commercials as an industry professional herself.